In 2006, a study by Jin-jun Huang, et. al., the efficacy of Jingjin therapy in treating migraine was investigated, aiming to explore a non-medical approach for managing this debilitating condition.

The study involved 100 migraine patients randomly allocated into two groups: an observation group and a control group, with 50 participants each. The observation group received Jingjin therapy, while the control group was administered oral Nimodipine.

Results indicated a remarkable total effective rate of 100.0% in the observation group, surpassing the 70.0% rate observed in the control group. This disparity between the two groups was statistically significant (P < 0.01). Furthermore, the observation group exhibited superior outcomes in parameters such as attack frequency, attack duration, headache severity index, and accompanying symptoms when compared to the control group (P < 0.01).

These findings highlight the notable therapeutic potential of Jingjin therapy in managing migraine symptoms. The study suggests that this non-medical intervention could offer a promising alternative or complementary approach to conventional medication for migraine management.

Further research and clinical trials are warranted to elucidate the underlying mechanisms of Jingjin therapy and to validate its efficacy in larger cohorts. Nonetheless, these initial findings signify a significant step forward in the pursuit of effective non-pharmacological treatments for migraine sufferers.

Reference: Huang, J. J., Pang, J., Lei, L. M., Chen, J. X., & He, Y. F. (2006). Observation on therapeutic effect of Jingjin therapy on migraine. Zhongguo Zhen jiu= Chinese Acupuncture & Moxibustion, 26(5), 322-324.